Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific Corporation

http://www.bostonscientific.com

Latest From Boston Scientific Corporation

FDA Is ‘Getting More Aggressive’ In Going After Drug Efficacy Claims Outside Label

Regulatory experts note there has been an uptick in enforcement letters objecting to efficacy presentations in Rx drug promotions that are not consistent with FDA-required labeling. Panelists at FDLI meeting also discuss the use of real-world evidence in prescription drug promotion.

Advertising, Marketing & Sales Real-World Evidence

Time For Oral Incretins To Prove Their Worth

Several crucial trial readouts in diabetes and obesity will come this year and next, and the stakes are high.

Clinical Trials Metabolic Disorders

Finance Watch: Lilly, Fosun Reveal Strategic Investments In Start-Ups, Growth-Stage Firms

Private Company Edition: Lilly will open a third accelerator, this time in San Diego, and Fosun partnered with Treehill to help later-stage firms get over the finish line. Also, Flagship – after recent UK investments – signals its next fund will total $3bn. ArrivoBio and Alto Neuroscience raised $45m each.

Financing Innovation

Merck As Anchor, Scale As Lever, Aurobindo Looks To Spar With Lonza, WuXi Group

Starting off with MSD as an anchor partner, Aurobindo plans to eventually spar with the likes of WuXi and Lonza while building scale for its biologics CDMO business. Meanwhile, EMA approval for a greenfield project in China and an US FDA nod for Ryzneuta, licensed from Yifan’s Evive Biotech, signal a boost.

Strategy Sales & Earnings
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Other Names / Subsidiaries
    • Apama Medical
    • Asthmatx
    • Atritech, Inc.
    • Augmenix, Inc.
    • Biocompatibles International plc
    • BridgePoint Medical, Inc.
    • BTG plc
    • BTG Specialty Pharmaceuticals
    • Cameron Health, Inc.
    • Cardiovascular Imaging Systems, Inc.
    • CellMed
    • Cosman Medical Inc.
    • CryoCor
    • Cryterion Medical, Inc.
    • Devoro Medical, Inc.
    • Ekos Corporation
    • EMcision, Ltd.
    • EndoTex Interventional Systems, Inc.
    • EndoChoice Holdings, Inc.
    • Enteric Medical Technologies, Inc.
    • Galil Medical, Inc.
    • Guidant Corporation
    • Intelect Medical, Inc.
    • IoGyn, Inc.
    • Labcoat Limited
    • Meadox Medicals, Inc.
    • Novate Medical Ltd.
    • nVision Medical Corporation
    • NxThera, Inc.
    • Pathworks Anatomic Pathology Laboratory
    • PneumRx Inc.
    • Precision Vascular Systems, Inc.
    • Protherics PLC
    • RadioTherapeutics Corporation
    • Revascular Therapeutics, Inc.
    • Roxwood Medical
    • Rubicon Medical Corporation
    • SCIMED, Inc.
    • Securus Medical Group, Inc.
    • Symetis SA
    • VENITI
    • Vessix Vascular, Inc.
    • Xlumena Inc.
UsernamePublicRestriction

Register